Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 von Hippel-Lindau Disease 1 Ulcer 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Liver Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioma, Capillary 1 Hemangioblastoma 1 Fallopian Tube Neoplasms 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

belzutifan 1 Watchful Waiting 1 Propranolol 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hemangioblastoma × Propranolol × Clear all

NCT05424016 2023-12-13

PRO-HEB

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting

von Hippel-Lindau Disease, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡